\
&
Contact us
\
&
Contact us
This was 2 weeks ago
LocationBrussels
The next round of calls from the Digital Europe Main Work Programme is expected to open in early November 2025. To help you prepare, the Digital Europe National Contact Points (NCPs) of Belgium, the Netherlands and Luxembourg, supported by the DEP4ALL Network, invite you to an Info Session and Matchmaking Event.
Join us to:
More details about the programme are available in the registration form.
Registration
Registration is now closed!
Register here
Deadline: 30 October 2025 (EOB)
Participation: Free of charge, but registration is mandatory.
Note: Places are limited and allocated on a first-come, first-served basis.
Consultants are not eligible to participate.
Who Should Attend
This event is open to researchers, public institutions, and companies/organisations based in Belgium, the Netherlands, or Luxembourg that are interested in joining the Digital Europe Programme as beneficiaries.
Can’t Attend in Person?
The info session will be livestreamed and recorded for those unable to join onsite.
Please note that matchmaking and networking activities are available only to onsite participants.
Networking Made Easy
The event is organised in collaboration with the B2Match Platform, where participants can:
Don’t have a profile yet? Register here: Home | Digital Europe Programme Matchmaking Platform
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Digital Europe Cybersecurity Defence
Research Infrastructures Culture and society Climate, Energy, Mobility
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
